GUILLERMO
LÓPEZ VIVANCO
Forscher bis um 2022
Fudan University
Shangai, ChinaPublikationen in Zusammenarbeit mit Forschern von Fudan University (1)
2012
-
First-line bevacizumab-containing therapy for breast cancer: Results in patients aged ≥70 years treated in the ATHENA study
Annals of Oncology, Vol. 23, Núm. 1, pp. 111-118